×
About 218 results

ALLMedicine™ Pediatric Rhabdomyosarcoma Center

Research & Reviews  107 results

Antitumor effects of curcumin in pediatric rhabdomyosarcoma in combination with chemoth...
https://doi.org/10.3892/ijo.2020.5155
International Journal of Oncology; Sorg C, Schmid E et. al.

Jan 25th, 2021 - Rhabdomyosarcoma (RMS), the most common pediatric soft tissue sarcoma, has an unfavorable outcome in advanced tumor stages with less than 30% failure‑free survival. Curcumin (CUR) is a promising drug in complementary oncology with few side effects...

Population-based survival of pediatric rhabdomyosarcoma of the head and neck over four ...
https://doi.org/10.1016/j.ijporl.2020.110599
International Journal of Pediatric Otorhinolaryngology; Curry SD, Jiang ZY et. al.

Jan 10th, 2021 - Clinical trials have reported increases in the survival of pediatric rhabdomyosarcoma (RMS) from 25% in 1970 to 73% in 2001. The purpose of this study was to examine whether survival of pediatric patients with RMS of the head and neck improved at ...

Germline Cancer-Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report from th...
https://doi.org/10.1093/jnci/djaa204
Journal of the National Cancer Institute; Li H, Sisoudiya SD et. al.

Dec 29th, 2020 - Several cancer-susceptibility syndromes are reported to underlie pediatric rhabdomyosarcoma (RMS); however, there have been no systematic efforts to characterize the heterogeneous genetic etiologies of this often-fatal malignancy. We performed exo...

Update on pediatric rhabdomyosarcoma: A report from the APSA Cancer Committee.
https://doi.org/10.1016/j.jpedsurg.2020.06.015
Journal of Pediatric Surgery; Rhee DS, Rodeberg DA et. al.

Jul 17th, 2020 - Rhabdomyosarcoma is the most common soft tissue sarcoma in children and young adults and requires multimodality treatment. The purpose of this review is to present an update on risk stratification as well as surgical and medical management strateg...

Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatme...
https://doi.org/10.3892/ijo.2020.5059
International Journal of Oncology; Regenbogen S, Stagno MJ et. al.

May 7th, 2020 - Rhabdomyosarcoma (RMS) is the most common type of pediatric soft tissue sarcoma. The prognosis of advanced stage RMS remains poor, and metastatic invasion is a major cause of treatment failure. Therefore, there is an urgent need for treatment alte...

see more →

Clinicaltrials.gov  111 results

Antitumor effects of curcumin in pediatric rhabdomyosarcoma in combination with chemoth...
https://doi.org/10.3892/ijo.2020.5155
International Journal of Oncology; Sorg C, Schmid E et. al.

Jan 25th, 2021 - Rhabdomyosarcoma (RMS), the most common pediatric soft tissue sarcoma, has an unfavorable outcome in advanced tumor stages with less than 30% failure‑free survival. Curcumin (CUR) is a promising drug in complementary oncology with few side effects...

Population-based survival of pediatric rhabdomyosarcoma of the head and neck over four ...
https://doi.org/10.1016/j.ijporl.2020.110599
International Journal of Pediatric Otorhinolaryngology; Curry SD, Jiang ZY et. al.

Jan 10th, 2021 - Clinical trials have reported increases in the survival of pediatric rhabdomyosarcoma (RMS) from 25% in 1970 to 73% in 2001. The purpose of this study was to examine whether survival of pediatric patients with RMS of the head and neck improved at ...

Germline Cancer-Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report from th...
https://doi.org/10.1093/jnci/djaa204
Journal of the National Cancer Institute; Li H, Sisoudiya SD et. al.

Dec 29th, 2020 - Several cancer-susceptibility syndromes are reported to underlie pediatric rhabdomyosarcoma (RMS); however, there have been no systematic efforts to characterize the heterogeneous genetic etiologies of this often-fatal malignancy. We performed exo...

Update on pediatric rhabdomyosarcoma: A report from the APSA Cancer Committee.
https://doi.org/10.1016/j.jpedsurg.2020.06.015
Journal of Pediatric Surgery; Rhee DS, Rodeberg DA et. al.

Jul 17th, 2020 - Rhabdomyosarcoma is the most common soft tissue sarcoma in children and young adults and requires multimodality treatment. The purpose of this review is to present an update on risk stratification as well as surgical and medical management strateg...

Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatme...
https://doi.org/10.3892/ijo.2020.5059
International Journal of Oncology; Regenbogen S, Stagno MJ et. al.

May 7th, 2020 - Rhabdomyosarcoma (RMS) is the most common type of pediatric soft tissue sarcoma. The prognosis of advanced stage RMS remains poor, and metastatic invasion is a major cause of treatment failure. Therefore, there is an urgent need for treatment alte...

see more →